LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Search

Twist Bioscience Corp

Closed

SectorHealthcare

32.25 -0.09

Overview

Share price change

24h

Current

Min

31.26

Max

33.18

Key metrics

By Trading Economics

Income

-48M

-27M

Sales

3M

99M

EPS

-0.45

Profit margin

-27.41

Employees

979

EBITDA

-2.3M

-26M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+17.65% upside

Market Stats

By TradingEconomics

Market Cap

-43M

1.8B

Previous open

32.34

Previous close

32.25

News Sentiment

By Acuity

50%

50%

166 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

8 Dec 2025, 23:48 UTC

Major Market Movers

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8 Dec 2025, 23:44 UTC

Market Talk

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8 Dec 2025, 23:42 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8 Dec 2025, 23:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 Dec 2025, 23:13 UTC

Market Talk

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8 Dec 2025, 23:09 UTC

Acquisitions, Mergers, Takeovers

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8 Dec 2025, 22:46 UTC

Market Talk

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8 Dec 2025, 22:01 UTC

Market Talk

Miners Poised to Do Well in 2026 -- Market Talk

8 Dec 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8 Dec 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8 Dec 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8 Dec 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8 Dec 2025, 21:51 UTC

Market Talk

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8 Dec 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

8 Dec 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 Dec 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 Dec 2025, 21:38 UTC

Acquisitions, Mergers, Takeovers

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8 Dec 2025, 21:38 UTC

Acquisitions, Mergers, Takeovers

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8 Dec 2025, 21:36 UTC

Market Talk

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8 Dec 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8 Dec 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 Dec 2025, 21:08 UTC

Market Talk

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8 Dec 2025, 20:38 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8 Dec 2025, 20:26 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 Dec 2025, 20:18 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8 Dec 2025, 20:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8 Dec 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8 Dec 2025, 20:05 UTC

Market Talk

Global Equities Roundup: Market Talk

8 Dec 2025, 20:05 UTC

Market Talk

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8 Dec 2025, 20:01 UTC

Market Talk

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

17.65% upside

12 Months Forecast

Average 38 USD  17.65%

High 42 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

166 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat